实用肝脏病杂志 ›› 2011, Vol. 14 ›› Issue (2): 110-111.doi: 10.3969/j.issn.1672-5069.2011.02.009

• 论著 • 上一篇    下一篇

阿德福韦酯治疗慢性乙型肝炎65例观察

李勇年,吴炜强,翟佩任,燕青松,那军,魏丽军,高建兴,郭晏海   

  1. 710054 西安市 解放军323医院感染病科(李勇年,吴炜强,翟佩任,燕青松,那军,魏丽军,高建兴);第四军医大学药学系基因研究所(郭晏海)
  • 收稿日期:2010-11-29 修回日期:2016-04-15 出版日期:2011-04-10 发布日期:2016-04-15
  • 作者简介:李勇年 男,50岁,医学博士,主任医师,硕士研究生导师。主要从事传染病和肝脏疾病的诊治研究。E-mail:yongnian@pub.xaonline.com

Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report

LI Yongnian,WU Weiqiang,ZHAI Peiren,et al.   

  1. Department of Infectious Diseases,The 323rd Hospital,Xi’an 710054,P.R.China
  • Received:2010-11-29 Revised:2016-04-15 Online:2011-04-10 Published:2016-04-15

摘要: 目的 探讨阿德福韦酯单独或联合拉米夫定治疗慢性乙型肝炎的疗效。方法 12例HBeAg阳性患者给予阿德福韦酯,39例HBeAg阳性患者给予拉米夫定和阿德福韦酯,14例HBeAg阴性患者接受阿德福韦酯治疗。各组均观察24个月。结果 联合治疗HBeAg阳性和阿德福韦酯治疗HBeAg阴性患者在治疗3个月、6个月、12个月和24个月时,血清HBV DNA水平均明显低于阿德福韦酯治疗HBeAg阳性患者;三组ALT复常率无显著性相差。结论 阿德福韦酯联合拉米夫定初始治疗HBeAg阳性或阿德福韦酯治疗HBeAg阴性慢性乙型肝炎患者均能取得较好的疗效。

关键词: 慢性乙型肝炎, 阿德福韦酯, 拉米夫定, 治疗

Abstract: Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B. Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks. Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different. Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.

Key words: Hepatitis B, Adefovir dipivoxil, Lamivudine, Efficacy